Agamree Priority Review by Canada for Duchenne Muscular Dystrophy
08 Apr 2025 //
GLOBENEWSWIRE
Catalyst, KYE Announce Canadian Federal Court Ruling on Approval of Ruzurgi
11 Mar 2022 //
GLOBENEWSWIRE
KYE Pharmaceuticals Announces Approval of CORZYNA™ in Canada
05 Jan 2021 //
NEWSWIRE